Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Cargo

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Seminars in Hematology|September 30, 2017
Individual risk assessment in MDS in the era of genomic medicineCatherine Cargo, David Bowen
The Lancet. Haematology|July 20, 2025
Clonal haematopoiesis to clonal cytopenias: unravelling disease evolution over timeKristina Kirschner, Yael Kusne, Catherine Cargo, et al.
The Clinical Teacher|March 13, 2012
Handwritten undergraduate case reportsKieran McGlade, Catherine Cargo, Damian Fogarty, et al.
Cancer Epidemiology|April 20, 2016
Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15Eve Roman, Alex Smith, Simon Appleton, et al.
International Journal of Cancer|April 30, 2026
Adverse Health Events in Chronic Myeloid Leukaemia Patients Treated With Tyrosine Kinase Inhibitors 2009-2019: A Real-World Study From the UK's Haematological Malignancy Research NetworkEleanor Kane, Alexandra Smith, Debra Howell, et al.
Case Reports in Hematology|May 12, 2015
Nonsecretory multiple myeloma presenting as an intestinal tumorDiana Triantafyllopoulou, Stuart Mellor, Catherine Cargo, et al.
Blood|January 5, 2019
The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosisCatherine Cargo, Matthew Cullen, Jan Taylor, et al.
Cancer Epidemiology|December 31, 2023
Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK's Haematological Malignancy Research NetworkMaxine Lamb, Daniel Painter, Debra Howell, et al.
British Journal of Haematology|August 3, 2022
Phase Ib study of eltrombopag and azacitidine in patients with high-risk myelodysplastic syndromes and related disorders (the ELASTIC study)Alexander Sternberg, Rebecca Boucher, Helen Chantal Coulthard, et al.
Frontiers in Immunology|March 8, 2021
Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important ComplicationAbdulla Watad, Mark Kacar, Nicola Luigi Bragazzi, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Seminars in Hematology|September 30, 2017
Individual risk assessment in MDS in the era of genomic medicineCatherine Cargo, David Bowen
The Lancet. Haematology|July 20, 2025
Clonal haematopoiesis to clonal cytopenias: unravelling disease evolution over timeKristina Kirschner, Yael Kusne, Catherine Cargo, et al.
The Clinical Teacher|March 13, 2012
Handwritten undergraduate case reportsKieran McGlade, Catherine Cargo, Damian Fogarty, et al.
Cancer Epidemiology|April 20, 2016
Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15Eve Roman, Alex Smith, Simon Appleton, et al.
International Journal of Cancer|April 30, 2026
Adverse Health Events in Chronic Myeloid Leukaemia Patients Treated With Tyrosine Kinase Inhibitors 2009-2019: A Real-World Study From the UK's Haematological Malignancy Research NetworkEleanor Kane, Alexandra Smith, Debra Howell, et al.
Case Reports in Hematology|May 12, 2015
Nonsecretory multiple myeloma presenting as an intestinal tumorDiana Triantafyllopoulou, Stuart Mellor, Catherine Cargo, et al.
Blood|January 5, 2019
The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosisCatherine Cargo, Matthew Cullen, Jan Taylor, et al.
Cancer Epidemiology|December 31, 2023
Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK's Haematological Malignancy Research NetworkMaxine Lamb, Daniel Painter, Debra Howell, et al.
British Journal of Haematology|August 3, 2022
Phase Ib study of eltrombopag and azacitidine in patients with high-risk myelodysplastic syndromes and related disorders (the ELASTIC study)Alexander Sternberg, Rebecca Boucher, Helen Chantal Coulthard, et al.
Frontiers in Immunology|March 8, 2021
Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important ComplicationAbdulla Watad, Mark Kacar, Nicola Luigi Bragazzi, et al.
Pageof 3